Just – Evotec Biologics enters $10m agreement with BARDA
Evotec’s subsidiary and CDMO, Just – Evotec Biologics, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to advance manufacturing optimisation for a monoclonal antibody cocktail. The therapy will target filovirus diseases, including Ebola virus (EBOV) and Sudan virus… Read More